- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06735092
Exercise Therapy and Orthoses in Lateral Elbow Tendinopathy: Comparative Effects
Investigation of the Effects of Different Types of Orthoses Used in Addition to Exercise Therapy in Lateral Elbow Tendinopathy
Study Overview
Status
Conditions
Detailed Description
This study was conducted under the supervision of Istanbul University-Cerrahpasa, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. It was designed as a single-centre, three-arm randomized controlled trial and included adults with unilateral lateral elbow tendinopathy who met the eligibility criteria and provided written informed consent. Participants were recruited from the Orthopedics and Traumatology Clinic of Basaksehir Cam and Sakura City Hospital. Participants were informed about the purpose, procedures, and potential risks of the study, and written informed consent was obtained from all participants. Following informed consent, 45 participants were randomly allocated in a 1:1:1 ratio to three groups:
- Exercise-Only Group
- Exercise + Counterforce Forearm Brace Group
- Exercise + Wrist Orthosis Group
All participants received education, activity modification, and the same physiotherapist-led progressive exercise program. Supervised exercise sessions were conducted twice weekly for 6 weeks, followed by a 6-week home exercise program. The exercise program consisted of wrist isometric, concentric, and eccentric exercises. Free-weight exercises were initiated with 0.5-1 kg weights according to individual tolerance, with progression achieved through 0.5-1 kg increments. For exercises using resistance bands, resistance was progressed by advancing to the next resistance level. Participants in Group 2 additionally used a counterforce forearm brace, whereas participants in Group 3 additionally used a wrist orthosis.
Participants were assessed at baseline, week 6, and week 12. The primary outcome was the Patient-Rated Tennis Elbow Evaluation (PRTEE). Secondary outcomes included resting and activity pain assessed using the Numeric Pain Rating Scale (NPRS), pain-free and maximum grip strength measured using a digital hand dynamometer, and perceived recovery assessed using the Global Rating of Change (GRC) scale. Sociodemographic and clinical characteristics were recorded using a case assessment form.
The collected data were analyzed using the Statistical Package for the Social Sciences (SPSS).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Buyukcekmece
-
Istanbul, Buyukcekmece, Turkey (Türkiye), 34500
- Faculty of Health Sciences, Istanbul University - Cerrahpasa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being between the ages of 18 and 65,
- Having a diagnosis of unilateral lateral elbow tendinopathy,
- Having at least two of the Thomsen, Maudsley, Mill's, or Cozen's tests positive during clinical examination,
- Experiencing symptoms for at least 3 months,
- Not having a systemic or chronic illness that would prevent participation in the treatment program.
Exclusion Criteria:
- A history of trauma or surgery in the relevant elbow and/or wrist,
- The presence of orthopedic and/or neurological problems in the cervical spine, shoulder joint, or wrist,
- Participation in a physiotherapy and rehabilitation program for lateral elbow tendinopathy within the last 6 months,
- Receiving any injections within the last 6 months,
- Systemic inflammatory disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Exercise-Only Group
This was the exercise-only group, in which participants received an exercise program without any additional support or devices such as braces.
This group was used to assess the effectiveness of exercise alone compared with other interventions involving braces.
A combined evidence-based exercise program consisting of wrist isometric, concentric, and eccentric exercises was applied to the participants in this group.
|
Participants in this group received a standardized exercise protocol.
The program consisted of an evidence-based combination of wrist isometric, concentric, and eccentric exercises.
Free-weight exercises were initiated with 0.5-1 kg weights, according to individual tolerance, and progressed by 0.5-1 kg increments.
For exercises using resistance bands, resistance was progressed by advancing to the next band level.
The supervised exercise program was conducted for 6 weeks, 2 days per week.
After the 6-week supervised treatment period, participants continued a 6-week home exercise program.
Participants were assessed at baseline, week 6, and week 12.
|
|
Active Comparator: Exercise + Forearm Counterforce Brace Group
This group received a combined treatment approach, including exercise therapy alongside the use of a forearm counterforce brace.
A combined evidence-based exercise program consisting of wrist isometric, concentric, and eccentric exercises was applied to the participants in this group.
|
Participants in this group received a standardized exercise protocol and a counterforce forearm brace in addition to exercise therapy.
The program consisted of an evidence-based combination of wrist isometric, concentric, and eccentric exercises.
Free-weight exercises were initiated with 0.5-1 kg weights, according to individual tolerance, and progressed by 0.5-1 kg increments.
For exercises using resistance bands, resistance was progressed by advancing to the next band level.
The supervised exercise program was conducted for 6 weeks, 2 days per week.
After the 6-week supervised treatment period, participants continued a 6-week home exercise program.
The counterforce forearm brace was positioned approximately 2.5 cm distal to the lateral epicondyle and was worn during daytime waking hours for 6 weeks.
Participants were instructed to remove the brace during sleep and supervised exercise sessions.
Participants were assessed at baseline, week 6, and week 12.
|
|
Active Comparator: Exercise + Wrist Orthosis Group
This group received a treatment combining exercise therapy with the use of a wrist orthosis.
A combined evidence-based exercise program consisting of wrist isometric, concentric, and eccentric exercises was applied to the participants in this group.
|
Participants in this group received a standardized exercise protocol and a wrist orthosis in addition to exercise therapy.
The program consisted of an evidence-based combination of wrist isometric, concentric, and eccentric exercises.
Free-weight exercises were initiated with 0.5-1 kg weights, according to individual tolerance, and progressed by 0.5-1 kg increments.
For exercises using resistance bands, resistance was progressed by advancing to the next band level.
The supervised exercise program was conducted for 6 weeks, 2 days per week.
After the 6-week supervised treatment period, participants continued a 6-week home exercise program.
The wrist orthosis maintained the wrist in slight extension and was worn during daytime waking hours for 6 weeks.
Participants were instructed to remove the orthosis during sleep and supervised exercise sessions.
Participants were assessed at baseline, week 6, and week 12.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-Rated Tennis Elbow Evaluation Questionnaire (PRTEE)
Time Frame: Baseline, week 6, week 12; primary endpoint = week 12
|
The Patient-Rated Tennis Elbow Evaluation (PRTEE) is a self-reported questionnaire designed to measure pain and functional limitations in individuals with lateral epicondylitis (tennis elbow).
It consists of 15 items divided into two subscales: pain (5 items) and functional disability (10 items).
Each item is rated on a scale from 0 (no pain or difficulty) to 10 (severe pain or difficulty), with a total score range of 0 to 100.
Higher scores indicate greater pain and disability, while lower scores reflect improvement.
The PRTEE is commonly used to assess treatment outcomes and track patient progress over time.
|
Baseline, week 6, week 12; primary endpoint = week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Resting Pain Intensity (Numeric Pain Rating Scale [NPRS])
Time Frame: Baseline, week 6, week 12
|
The Numeric Pain Rating Scale (NPRS) is a subjective measure used to assess pain intensity.
It is a 0-10 scale, where 0 indicates "no pain" and 10 represents "the worst pain imaginable."
Patients are asked to rate their pain level at rest during the previous 24 hours based on this scale.
A decrease in the NPRS score indicates an improvement or reduction in pain, while an increase suggests worsening pain.
It is a simple and widely used tool for monitoring pain in clinical and research settings.
|
Baseline, week 6, week 12
|
|
Activity Pain Intensity (Numeric Pain Rating Scale [NPRS])
Time Frame: Baseline, week 6, week 12
|
The Numeric Pain Rating Scale (NPRS) is a subjective measure used to assess pain intensity.
It is a 0-10 scale, where 0 indicates "no pain" and 10 represents "the worst pain imaginable."
Patients are asked to rate their pain level during activity based on this scale.
A decrease in the NPRS score indicates an improvement or reduction in pain, while an increase suggests worsening pain.
It is a simple and widely used tool for monitoring pain in clinical and research settings.
|
Baseline, week 6, week 12
|
|
Pain-Free Grip Strength
Time Frame: Baseline, week 6, week 12
|
Pain-free grip strength is a measure of grip force that can be exerted without provoking pain.
It was assessed using a digital hand dynamometer.
Participants were instructed to gradually increase their grip force until they first experienced pain, and the grip force at that point was recorded.
An increase in pain-free grip strength indicates an improvement in grip performance and pain tolerance.
|
Baseline, week 6, week 12
|
|
Maximum Grip Strength
Time Frame: Baseline, week 6, week 12
|
Maximum grip strength is a measure of the maximum force that can be generated during a grip.
It was assessed using a digital hand dynamometer.
Participants were instructed to squeeze the dynamometer as strongly as possible, and the maximum grip force was recorded.
An increase in maximum grip strength indicates an improvement in grip performance.
|
Baseline, week 6, week 12
|
|
Global Rating of Change (GRC)
Time Frame: Week 6, week 12
|
The Global Rating of Change (GRC) scale is a subjective measure used to assess patients' perceived change in their condition following treatment.
Participants compare their current condition with their condition before treatment and rate their perceived change.
In this study, the GRC was used to assess patients' perceived recovery at weeks 6 and 12.
For analysis, responses were categorized as unchanged, better, or much better.
|
Week 6, week 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Büşra Kültür, MSc, Istanbul University - Cerrahpasa
- Study Director: Derya Çelik, Prof. Dr., Istanbul University - Cerrahpasa
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Elbow Tendinopathy
- Elbow Injuries
- Neurologic Manifestations
- Musculoskeletal Diseases
- Muscular Diseases
- Wounds and Injuries
- Tendon Injuries
- Arm Injuries
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Pain
- Tendinopathy
- Tennis Elbow
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Exercise
Other Study ID Numbers
- IstanbulUC-FTR-B-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.